• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Caspase recruitment domain-containing protein 17 (CARD17)

ACP17001

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17001 Target NameCARD17
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-110Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5XLA6
Background Information
  • Uniprot Id

    Q5XLA6

  • Target Species

    Human

  • Target Name

    CARD17P

  • Target Full Name

    Putative caspase recruitment domain-containing protein 17P

  • Target Function

    Regulator of procaspase-1/CASP1 activation implicated in the regulation of the proteolytic maturation of pro-IL-1beta/IL1B and its release during inflammation. Inhibits the release of IL1B in response to LPS in monocytes. However, unlike CASP1, do not induce NF-kappa-B activation.

  • Target Subcellular Location

    Cytoplasm.

  • Target Tissue Specificity

    Ubiquitous.

  • Target Research Area

    Cell Biology

  • Target Synonyms

    CAR17_HUMAN; CARD 17; CARD17; Caspase 1 inhibitor; Caspase recruitment domain containing protein 17; Caspase recruitment domain-containing protein 17; Caspase-1 inhibitor INCA; Caspase1 inhibitor; Inhibitory caspase recruitment domain (CARD) protein; Inhibitory caspase recruitment domain protein

Inquire Recombinant Human Caspase recruitment domain-containing protein 17 (CARD17) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification